Certain Sections of this Indenture relating toIndenture • May 15th, 2024 • MSD Netherlands Capital B.V. • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ], 20[ ], among MSD Netherlands Capital B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of The Netherlands, with its corporate seat (statutaire zetel) in Haarlem, The Netherlands, and its registered office at Waarderweg 39, 2031BN Haarlem, The Netherlands, registered with the Trade Register of the Dutch Chamber of Commerce (Kamer van Koophandel) under number 93598734 (the “Company”), Merck & Co., Inc., a corporation duly organized and existing under the laws of the State of New Jersey (herein called the “Parent Guarantor”), having its principal office at 126 East Lincoln Avenue, Rahway, New Jersey 07065, and U.S. Bank Trust National Association, a national banking association, as Trustee (herein called the “Trustee”).
MSD Netherlands Capital B.V. Form of Debt Underwriting AgreementDebt Underwriting Agreement • May 15th, 2024 • MSD Netherlands Capital B.V. • Pharmaceutical preparations
In connection with the issuance of the Securities, the Issuer and the Guarantor will enter into a paying agency agreement (the “Paying Agency Agreement”), expected to be dated as of , 20 , among the Issuer, the Guarantor and , as paying agent, and , as trustee, transfer agent and security registrar (the “Trustee”).
